Evrenzo®

Active substance roxadustat
Holder Astellas Pharma B.V.
Status closed
Indication treatment of symptomatic anaemia of Chronic Kidney Disease in non-dialysis and dialysis patients, and where use of available treatment (IV iron or injectable ESAs) is not appropriate or is expected not to be appropriate, or patients who have a known contraindication for the currently available treatment or who do not tolerate the currently available treatment, or are expected not to tolerate this product
Public documents

Approbation

Approbation-Amendment_1

 

Information for the patient

Information for the patient-Amendment_1

 

Informed Consent

Informed consent-Amendment_1

Laast update 22/01/2024

 

Last updated on 13/02/2024